- $1.09bn
- $1.65bn
- $1.57bn
- 48
- 57
- 77
- 63
2018 December 29th | 2019 December 28th | 2020 December 26th | 2021 December 25th | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 943 | 1,299 | 1,356 | 1,425 | 1,573 |
Cost of Revenue | |||||
Gross Profit | 324 | 384 | 415 | 500 | 536 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,134 | 1,649 | 1,511 | 1,513 | 1,618 |
Operating Profit | -191 | -350 | -155 | -87.5 | -44.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -215 | -384 | -201 | -159 | -55.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -214 | -387 | -207 | -171 | -76 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -214 | -387 | -207 | -171 | -76 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -214 | -387 | -207 | -171 | -76 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.21 | -1.65 | -0.947 | -0.775 | -0.367 |